Call to arrange a consultation
+1 416 777 0888

AstraZeneca Canada Inc. et al. v Sandoz Canada Inc.

T-28-20
Pending
New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations relating to Patent No. 2,402,894 (saxagliptin)

Counsel to: 
Sandoz Canada Inc.
here.

Meet the team